Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Angelo M. De Marzo"'
Autor:
Susan L. Dalrymple, Yezi Zhu, Peter S. Nelson, Jun Luo, Jianfeng Xu, Alan K. Meeker, Samuel R. Denmeade, Emmanuel S. Antonarakis, S. Lilly Zheng, William B. Isaacs, Angelo M. De Marzo, Jody E. Hooper, Ilsa Coleman, John T. Isaacs, W. Nathaniel Brennen
Publikováno v:
Oncogene
The role of truncated androgen receptor splice variant-7 (AR-V7) in prostate cancer biology is an unresolved question. Is it simply a marker of resistance to 2nd-generation androgen receptor signaling inhibitors (ARSi) like abiraterone acetate (Abi)
Autor:
Angelo M. De Marzo, Jeffrey J. Tosoian, Tamara L. Lotan, Ashley E. Ross, Mufaddal Mamawala, Liana B. Guedes, H. Ballentine Carter, Bruce J. Trock, Misop Han, Carlos L. Morais
Publikováno v:
Prostate cancer and prostatic diseases
Background: Up to half of men with Gleason score 6 (GS6) prostate cancers initially managed with active surveillance (AS) will eventually require definitive therapy, usually due to tumor grade reclassification during follow-up. We examined the associ
Autor:
Jiayun Lu, Tamara L. Lotan, Logan Reitz, Harsimar B. Kaur, Jeffrey J. Tosoian, Angelo M. De Marzo, John R. Barber, Scott A. Tomlins, Karen S. Sfanos, Corinne E. Joshu, Edward M. Schaeffer, Liana B. Guedes, Laneisha Maldonado
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
The inflammatory microenvironment plays an important role in the pathogenesis and progression of tumors and may be associated with somatic genomic alterations. We examined the association of tumor-infiltrating T-cell density with clinical-pathologic
Autor:
Angelo M. De Marzo, Misop Han, Elizabeth B. Humphreys, Fawaz Almutairi, Ashley E. Ross, Jessica Hicks, Stephanie Glavaris, Edward M. Schaeffer, Tamara L. Lotan, Debasish Sundi, Carlos L. Morais, Jeffrey J. Tosoian, Bruce J. Trock, Scott A. Tomlins
Publikováno v:
European Urology. 71:697-700
African-American (AA) men have a higher risk of lethal prostate cancer (PCa) compared to European-American (EA) men. However, the molecular basis of this difference, if any, remains unclear. In EA PCa, PTEN loss, but not ERG rearrangement, has been a
Autor:
Angelo M. De Marzo, Tamara L. Lotan, Jessica Hicks, Carlos L. Morais, Alexander S. Baras, Liana B. Guedes
Publikováno v:
Human Pathology. 55:117-125
High-grade prostatic intraepithelial neoplasia (HGPIN) is widely believed to represent a precursor to invasive prostatic adenocarcinoma. However, recent molecular studies have suggested that retrograde spread of invasive adenocarcinoma into pre-exist
Autor:
Francesca Khani, Jonathan I. Epstein, Colin C. Pritchard, Jessica L. Hicks, Christopher E. Barbieri, Angelo M. De Marzo, Tamara L. Lotan, Sara E. Wobker, Brian D. Robinson
Publikováno v:
The Journal of pathologyReferences. 249(1)
Intraductal carcinoma of the prostate (IDC-P) most often appears associated with high-grade invasive prostate carcinoma (PCa), where it is believed to represent retrograde spread. However, IDC-P rarely occurs as an isolated finding at radical prostat
Autor:
Jeong S. Han, Michael S. Nagar, Ming Zhou, Angelo M. De Marzo, Ann E. Anderson, Rajal B. Shah, Jennifer Gordetsky, Cristina Magi-Galluzzi, Jessica Hicks, Jonathan I. Epstein, Tamara L. Lotan, Stephen J. Lee, Carlos L. Morais
Publikováno v:
American Journal of Surgical Pathology. 39:169-178
Intraductal carcinoma of the prostate and high-grade prostatic intraepithelial neoplasia (PIN) have markedly different implications for patient care but can be difficult to distinguish in needle biopsies. In radical prostatectomies, we demonstrated t
Autor:
Roula Albadine, Alcides Chaux, Mohamad E. Allaf, George J. Netto, Luciana Schultz, Angelo M. De Marzo, Victor E. Reuter, Michael A. Carducci, Jenny J. Kim, Jessica Hicks, Ronald Rodriguez, Hans J. Hammers, Pedram Argani
Publikováno v:
American Journal of Surgical Pathology. 35:1549-1556
The need for effective targeted therapies for renal cell carcinomas (RCCs) has fueled the interest for understanding molecular pathways involved in the oncogenesis of kidney tumors. Aiming to analyze the expression status and prognostic significance
Autor:
Angelo M. De Marzo, Filipe L.F. Carvalho, Elizabeth A. Platz, Sarah B. Peskoe, Jessica L. Hicks, Jennifer Good, Elizabeth B. Humphreys, David M. Berman, Jeremy A. Squire, Misop Han, Helen L. Fedor, Tamara L. Lotan
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Universidade de São Paulo (USP)
instacron:USP
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
When distinguishing between indolent and potentially harmful prostate cancers, the Gleason score is the most important variable, but may be inaccurate in biopsies due to tumor under-sampling. This study investigated whether a molecular feature, PTEN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::307dd8707672207b737db8bdb047c7c6
Autor:
Andreas Pettersson, Stephen P. Finn, Rebecca E. Graff, Jennifer R. Rider, Travis Gerke, Massimo Loda, Carlos L. Morais, Michelangelo Fiorentino, Kathryn M. Wilson, Richard Flavin, Thomas U. Ahearn, Lorelei A. Mucci, Angelo M. De Marzo, Tamara L. Lotan, Howard D. Sesso, Edward Giovannucci, Meir J. Stampfer, Ericka M. Ebot, Jessica Hicks
Publikováno v:
Journal of the National Cancer Institute. 108:djv346
none 19 si First published online November 27, 2015 BACKGROUND: PTEN is a tumor suppressor frequently deleted in prostate cancer that may be a useful prognostic biomarker. However, the association of PTEN loss with lethal disease has not been tested